Insider Trading May 12, 2026 07:16 PM

Lumentum Director Ian Small Executes $3.19 Million Stock Sale Amid Recent Market Growth

The transaction occurred as LITE shares continue to trade significantly above recent sale prices and prepare for Nasdaq-100 inclusion.

By Hana Yamamoto LITE

Ian Small, a member of the Board of Directors at Lumentum Holdings Inc. (NASDAQ:LITE), has completed a series of stock sales totaling $3,189,108. These transactions, which took place on May 8, 2026, involved the direct disposal of 3,500 shares of common stock. The sale comes during a period of significant price appreciation for LITE, with the stock having seen a surge of 1,284% over the preceding year.

Lumentum Director Ian Small Executes $3.19 Million Stock Sale Amid Recent Market Growth
LITE

Key Points

  • Director Ian Small sold 3,500 shares at a weighted average price between $910.71 and $912.26.
  • Lumentum is set to join the Nasdaq-100 Index on May 18, 2026, replacing CoStar Group Inc.
  • BofA Securities raised Lumentum's price target to $1,100 based on improved margin outlooks.

Lumentum Holdings Inc. (NASDAQ: LITE) director Ian Small has offloaded common stock in a series of transactions totaling approximately $3.19 million. On May 8, 2026, Mr. Small executed the sale of 3,500 shares through multiple trades at weighted average prices ranging from $910.7185 to $912.2644 per share.



Detailed Breakdown of Transactions

The disposal of shares was conducted in three distinct tranches:

  • The first portion consisted of 2,037 shares sold at a weighted average price of $910.7185. Individual trades within this block were executed at prices between $910.02 and $911.01.
  • A second block of 892 shares was sold with a weighted average price of $911.5152, involving individual transaction prices between $911.025 and $911.96.
  • The final segment involved 571 shares, which were disposed of at a weighted average price of $912.2644, with trade prices ranging from $912.07 to $912.72.

Following these disposals, Mr. Small maintains a direct holding of 25,962 shares of Lumentum Holdings Inc. common stock.



Market Context and Valuation

The timing of the insider sale coincides with a period of intense upward momentum for LITE. Over the last year, LITE shares have experienced a 1,284% increase. At the time of reporting, the stock was trading at $992.62, a level notably higher than the weighted average prices achieved in Mr. Small's May sales. Analysis from InvestingPro suggests that the current share price may be overvalued relative to its Fair Value, noting a P/E ratio of 184.83.

Despite these valuation concerns, Lumentum has demonstrated strong recent financial performance. In its third-quarter fiscal year 2026 earnings report, the company exceeded analyst expectations on both the top and bottom lines. Lumentum reported revenue of $808.4 million, which was higher than the anticipated $802.94 million, and delivered an earnings per share (EPS) of $2.37, surpassing the forecasted $2.26.



Strategic Milestones and Analyst Outlook

Lumentum is currently undergoing a significant transition in market prominence. On May 18, 2026, the company is scheduled to join the Nasdaq-100 Index, where it will replace CoStar Group Inc. This move is expected to highlight its increasing importance within the broader market.

Financial institutions have also adjusted their outlooks following recent developments. BofA Securities has raised its price target for Lumentum from $775 to $1,100, citing an improved outlook regarding margins. Additionally, the firm has increased its earnings estimates for upcoming fiscal years, projecting EPS of $13.80 for fiscal year 2026 and $22 for fiscal year 2027. While these indicators are positive, the stock did face a slight decline in pre-market trading.



Key Insights

  • Insider Activity: The sale of $3.19 million in shares by a director provides insight into internal liquidity events during a period of high valuation.
  • Market Expansion: The upcoming inclusion in the Nasdaq-100 Index represents a major milestone for Lumentum's market recognition and institutional standing.
  • Financial Momentum: Recent earnings beats and upgraded price targets from BofA Securities suggest ongoing strategic progress in margin management and profitability.

Risks and Uncertainties

  • Valuation Risks: With a P/E ratio of 184.83, there is an explicit indication that the stock may be trading above its calculated Fair Value, posing risks to investors if market sentiment shifts.
  • Market Volatility: Despite strong earnings and price target hikes, the stock has shown susceptibility to minor declines in pre-market sessions, reflecting broader market fluctuations.

Risks

  • The stock may be overvalued according to Fair Value metrics with a P/E ratio of 184.83.
  • Recent pre-market trading showed minor declines despite positive earnings and price target upgrades.

More from Insider Trading

Zoetis Director Michael McCallister Executes $233,273 Insider Stock Purchase May 12, 2026 Ultra Clean Holdings Executive Executes Stock Sale Amid High Valuation and Strong Market Sentiment May 12, 2026 Ultra Clean Holdings Executive Liquidates Shares Amid Recent Valuation Shifts May 12, 2026 Benchmark Electronics Director Executes $1.98 Million Stock Sale May 12, 2026 Medifast Director Executes Multi-Transaction Stock Purchase Amid Mixed Quarterly Results May 12, 2026